Descriptor English: | Placebos | ||||
Descriptor Spanish: |
Placebos
| ||||
Descriptor Portuguese: | Placebos | ||||
Descriptor French: | Placebo | ||||
Entry term(s): |
Sham Treatment |
||||
Tree number(s): |
D26.660 E02.785 HP3.073.433 HP7.007.130 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010919 | ||||
Scope note: | Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. |
||||
Annotation: | usually NIM; do not index routinely for articles on CLINICAL TRIALS AS TOPIC; DOUBLE-BLIND METHOD; etc., unless particularly discussed; Manual 18.12.13 |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis CH chemistry CL classification CS chemical synthesis EC economics HI history IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use |
||||
DeCS ID: | 11350 | ||||
Unique ID: | D010919 | ||||
NLM Classification: | WB 330 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1966/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2009/07/13 |
-
-
CHEMICALS AND DRUGS
Pharmaceutical Preparations [D26]Pharmaceutical Preparations -
ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT
Therapeutics [E02]Therapeutics
|
Placebos
- Preferred
Concept UI |
M0016932 |
Scope note | Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. |
Preferred term | Placebos |
Entry term(s) |
Sham Treatment |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey